Clinical Trials in Michigan Center, Michigan
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD.102 enrolled30 locationsNCT05389215
Recruiting
Early Phase 1
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
Advanced Refractory Solid TumorsSubjects Considered Likely to Respond to CB-03-10
Cosmo Technologies Ltd90 enrolled6 locationsNCT03863145